ANTX - AN2 Therapeutics, In...

Corporate Actions of AN2 Therapeutics, Inc.(ANTX), AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments

AN2 Therapeutics, Inc.

ANTX

NASDAQ

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.

2.32 USD

0.04 (1.72%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Earnings

We are unable to load the chart at this time.

Dividends

We are unable to load the chart at this time.

Splits

We are unable to load the chart at this time.

From:

To:

Date

Revenue

Earnings

Estimated Earnings

Surprise

No data found!

FMP

Home Terms of Service Privacy Policy Blog FAQs Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.